| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/05/2000 | CN1249342A Human phosphatidyl ethanolamine-N-methyltransferase, its coding sequence and its preparing process |
| 04/05/2000 | CN1249341A Human protein kinase C arrestin coding sequence, its encoded polypeptide and its preparing process |
| 04/05/2000 | CN1249340A Human mitochondrial matrix GTP : AMP phosphotransferase, its encode sequence and its preparing process |
| 04/05/2000 | CN1249339A Core sequence of sex-determining genes for milk cow and its application |
| 04/05/2000 | CN1249310A Cationic polypeptide process for expressing antimicrobe in plant |
| 04/05/2000 | CN1051110C Method and related reagent box for sieve examination of leukemia and its tissue |
| 04/05/2000 | CN1051091C Method for detecting antibodies to hepatitis C virus |
| 04/05/2000 | CN1050968C Method and apparatus for inducing controlled stressed behavior in animals |
| 04/04/2000 | US6046384 Papaya ringspot virus NIa protease gene |
| 04/04/2000 | US6046382 Plants with modified flowers |
| 04/04/2000 | US6046381 Apolipoprotein E transgenic mice and assay methods |
| 04/04/2000 | US6046380 Dna which is modified at cryptic splice sites; for improved yield and gene therapy |
| 04/04/2000 | US6046321 Compound of 8 to 30 nucleobases targeted to nucleic acid encoding human g protein involved in hormonal inhibition of adenylyl cyclase and regulation of plasma membrane enzymes; for diagnosis, prophylaxis and treatment of related diseases |
| 04/04/2000 | US6046320 Compound 8 to 30 nucleobases in length which hybridizes a human nucleic acid which encodes an oncogene, mdm2-like p53 binding protein; for therapy or prophylaxis of related diseases |
| 04/04/2000 | US6046319 Antisense oligodeoxynucleotides regulating expression of TNF-α |
| 04/04/2000 | US6046318 Isolated cdna which encodes a protein having one or more cysteine containing domains; for diagnosis, therapy, recombinant production, and as probes to isolate related proteins in other species and organisms |
| 04/04/2000 | US6046317 For screening for carrier status and diagnosis of predisposition for increased serum cholesterol or low density lipoprotein cholesterol level in humans |
| 04/04/2000 | US6046316 Nucleotide sequence of soluble protein expressed exclusively in tumor cells; for diagnostic probes |
| 04/04/2000 | US6046314 Spα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 04/04/2000 | US6046308 Isolated TRBP polypeptides and uses therefor |
| 04/04/2000 | US6046307 Modulation of mammalian telomerase by peptide nucleic acids |
| 04/04/2000 | US6046246 Process for making fluorinated polymer adsorbent particles |
| 04/04/2000 | US6046175 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
| 04/04/2000 | US6046173 Polyoma virus pseudocapsids and method to deliver material into cell |
| 04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
| 04/04/2000 | US6046158 Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof |
| 04/04/2000 | US6046157 Modulation of TGF-β by recombinant TGF-β type II receptor polypeptides |
| 04/04/2000 | US6046050 Human liver cell line |
| 04/04/2000 | US6046049 Compound 8 to 30 nucleobases in length targeted to 3' untranslated region of nucleic acid which encodes human phosphatidyl inositol 3' kinase p110 delta isoform found in leukocytes; diagnosis, treatment of related diseases |
| 04/04/2000 | US6046047 Genetic construct encoding a chimeric protein with a domain which binds and crosslinks a synthetic, membrane permeable, non-peptide ligand and domain to cause cellular localization of complex; for gene therapy and inducible gene expression |
| 04/04/2000 | US6046044 Cisplatin resistance proteins |
| 04/04/2000 | US6046042 Amino acid sequence; for preferentially producing (s)-cyanohydrins |
| 04/04/2000 | US6046039 Methods for producing partially digested restriction DNA fragments and for producing a partially modified PCR product |
| 04/04/2000 | US6046038 Optimally labeled oligonucleotides |
| 04/04/2000 | US6046037 Method for producing immunoglobulins containing protection proteins in plants and their use |
| 04/04/2000 | US6046035 Polynucleotides encoding a cardiotrophin-like cytokine |
| 04/04/2000 | US6046034 Thermostable variants of human interferon-γ(IFN-γ) |
| 04/04/2000 | US6046033 Basic osteoblast growth factor II (bOGF-II) |
| 04/04/2000 | US6046031 Metalloproteinases |
| 04/04/2000 | US6046030 For the treatment of neurological disorders such as alzheimer's disease, multiple sclerosis and abnormal neural development; endocrine disorders such as diabetes; and heart disease, among others and diagnostic assays for such |
| 04/04/2000 | US6046028 Polynucleotides encoding insulin homolog zins3 |
| 04/04/2000 | US6046027 Human retinoid binding protein |
| 04/04/2000 | US6046026 cDNAs encoding proteins closely related to opioid receptors |
| 04/04/2000 | US6046025 Expression of heterologous proteins in drosophila cells |
| 04/04/2000 | US6046015 Modulating Robo: ligand interactions |
| 04/04/2000 | US6046011 Mammalian adrenocorticotropic hormone receptors and uses |
| 04/04/2000 | US6046009 Diagnosis and treatment of glaucoma |
| 04/04/2000 | US6046006 Sequential hybridization of fungal cell DNA and method for the detection of fungal cells in clinical material |
| 04/04/2000 | US6046005 Nucleic acid sequencing with solid phase capturable terminators comprising a cleavable linking group |
| 04/04/2000 | US6046004 Solution hybridization of nucleic acids with antisense probes having modified backbones |
| 04/04/2000 | US6046003 Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
| 04/04/2000 | US6046000 Method for identifying genes encoding signal sequences |
| 04/04/2000 | US6045999 Transcription factor E2F-4 |
| 04/04/2000 | US6045998 Technique for differential display |
| 04/04/2000 | US6045997 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
| 04/04/2000 | US6045994 Selective restriction fragment amplification: fingerprinting |
| 04/04/2000 | US6045993 Method, reagent and kit for genotyping of human papillomavirus |
| 04/04/2000 | US6045991 Luciferin ring system and an exocyclic enol phosphate group where the position on the luciferin ring system adjacent to the double bond is disubstituted; cationic aromatic compound; reaction with a phosphatase enzyme |
| 04/04/2000 | US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/04/2000 | US6045807 Method for production of neuroblasts |
| 04/04/2000 | US6045803 Administering to an avian a recombinant herpesvirus of turkeys for expressing an antigenic polypeptide to treat viral diseases |
| 04/04/2000 | US6045802 Antitumor agents treating cancer |
| 04/04/2000 | US6045799 Inducing infertility in a mammal by administering a recombinant chimeric protein in a diluent, adjuvant or carrier |
| 04/04/2000 | US6045798 Membrane-associated immunogens of mycobacteria |
| 04/04/2000 | US6045792 Human proteins kinases |
| 04/04/2000 | US6045789 Bystander effect tumoricidal therapy by expressing an HSV-tk gene |
| 04/04/2000 | US6045727 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| 04/04/2000 | US6044967 Plate-shaped holder housing for daily use and/or consumer articles |
| 04/04/2000 | CA2255673C Promoter elements conferring root-preferred gene expression |
| 04/04/2000 | CA2173878C Polynucleotide for treating systemic lupus erythematosus |
| 04/04/2000 | CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins |
| 04/04/2000 | CA2084339C Method of sexing bovine embryos |
| 04/04/2000 | CA2048676C Artificial promoter for the expression of proteins in yeast |
| 04/04/2000 | CA2045475C Blood-coagulation factor xiia .beta. monoclonal antibody and immunoassay |
| 04/04/2000 | CA2002540C Dna sequence coding for the human ix factor or a similar protein, expression vector, transformed cells, process for the preparation of ix factor and products obtained |
| 04/04/2000 | CA1340942C Processes for the treatment of vascular disease |
| 04/02/2000 | CA2246664A1 Vascular specific regulatory elements contained in the desmin 5' flanking region |
| 03/30/2000 | WO2000017655A1 Water-soluble fluorescent semiconductor nanocrystals |
| 03/30/2000 | WO2000017644A1 Ndp |
| 03/30/2000 | WO2000017643A2 A system for cell-based screening |
| 03/30/2000 | WO2000017642A2 Biological applications of semiconductor nanocrystals |
| 03/30/2000 | WO2000017641A1 Gpr10 as a target for identifying weight modulating compounds |
| 03/30/2000 | WO2000017400A1 ANTISENSE MODULATION OF cREL EXPRESSION |
| 03/30/2000 | WO2000017398A1 Parallel selex |
| 03/30/2000 | WO2000017396A1 Method for obtaining human skin dna samples with an adhesive sheet |
| 03/30/2000 | WO2000017394A1 Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 03/30/2000 | WO2000017393A1 Polymorphisms in the human beta1 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases |
| 03/30/2000 | WO2000017392A1 Polymorphisms in the human vcam-1 gene, suitable for diagnosis and treatment of vcam-1 ligand mediated diseases |
| 03/30/2000 | WO2000017391A1 Identification of microorganisms causing acute respiratory tract infections (ari) |
| 03/30/2000 | WO2000017390A1 Dna amplification of a single cell |
| 03/30/2000 | WO2000017387A1 Production and use of antimicrobial agents |
| 03/30/2000 | WO2000017377A2 Methods for large-scale production of recombinant aav vectors |
| 03/30/2000 | WO2000017376A1 Replication deficient retroviral vector system and methods of using |
| 03/30/2000 | WO2000017375A2 Method to treat haemophilia by in vivo gene therapy with retroviral vectors |
| 03/30/2000 | WO2000017374A1 Retroviral particles protected against complement mediated destruction |
| 03/30/2000 | WO2000017373A1 Recombinant celo virus and celo virus dna |
| 03/30/2000 | WO2000017372A2 Pineapple mealybug-associated wilt virus proteins and their uses |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017370A1 HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE) |